11:21am ET
Health and Healthcare
Mylan’s Shareholders Act As LBO Lenders
Mylan Labs (MYL-NYSE) is seeing its shares take a beating because it is acquiring Merck KGaA’s generic unit and Mylan is the acquirer in what is a very leveraged buyout. It isn’t…
